Harmony Biosciences Holdings, Inc.
HRMY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,611 | $1,816 | $1,902 | $1,965 |
| - Cash | $647 | $546 | $489 | $453 |
| + Debt | $170 | $173 | $177 | $181 |
| Enterprise Value | $1,134 | $1,443 | $1,591 | $1,693 |
| Revenue | $239 | $200 | $185 | $201 |
| % Growth | 19.4% | 8.5% | -8.2% | – |
| Gross Profit | $180 | $162 | $153 | $147 |
| % Margin | 75.1% | 81% | 82.7% | 73% |
| EBITDA | $73 | $59 | $67 | $66 |
| % Margin | 30.7% | 29.6% | 36.3% | 33% |
| Net Income | $51 | $40 | $46 | $49 |
| % Margin | 21.2% | 19.8% | 24.7% | 24.6% |
| EPS Diluted | 0.87 | 0.68 | 0.78 | 0.85 |
| % Growth | 27.9% | -12.8% | -8.2% | – |
| Operating Cash Flow | $109 | $79 | $34 | $76 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | $109 | $79 | $34 | $75 |